Skip to main content
logo
Sana Biotechnology, Inc. (SANA)
NASDAQ: SANA · Real-Time Price · USD
2.370
+0.030 (1.28%)
At close: Nov 6, 2026, 4:00 PM EST
2.360
-0.010 (-0.42%)
After-hours: Nov 6, 2026, 7:49 PM EST

Sana Biotechnology Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
-149.27-244.17-266.76-283.26-269.48-355.93
Depreciation & Amortization
10.6512.7515.517.5415.6311.07
Asset Writedown & Restructuring Costs
-44.611.897.01--
Stock-Based Compensation
22.6725.4637.6835.5338.3422.36
Other Operating Activities
-17.3827.63-10.28-49.03-82.0861.64
Change in Accounts Payable
-0.04-3.551.381.031.06-0.27
Change in Other Net Operating Assets
-8.2-6.57-2.5617.586.4810.07
Operating Cash Flow
-141.56-143.83-223.15-253.58-290.05-251.05
Operating Cash Flow Growth
------

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-3.57-0.94-33.43-20.03-20.88-29.86
Sale of Property, Plant & Equipment
0.981.43----
Investment in Securities
-29.63-40.7350.88192.04231.44-211.36
Other Investing Activities
------4.57
Investing Cash Flow
-32.23-40.2417.45172.01210.56-245.8

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Long-Term Debt Issued
--7.74---
Long-Term Debt Repaid
--0.35----
Net Debt Issued (Repaid)
-0.37-0.357.74---
Issuance of Common Stock
111.47129.08192.0131.654.91631.75
Financing Cash Flow
111.1128.73199.7531.654.91631.75

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Cash Flow
-62.69-55.33-5.95-49.92-74.58134.9

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
-145.14-144.77-256.58-273.61-310.93-280.92
Free Cash Flow Growth
------
Free Cash Flow Per Share
-0.50-0.57-1.11-1.41-1.65-1.69
Levered Free Cash Flow
-17.25-53.57-168.3-206.93-140.89-138.16
Unlevered Free Cash Flow
-17.25-53.57-168.3-206.93-140.89-138.16

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Change in Working Capital
-8.23-10.11-1.1918.617.549.8
SEC Filings: 10-K · 10-Q